Mutation Surveyor, GeneMarker and ChimerMarker licences come from Biogene
- Birmingham Women's and Children's NHS Foundation Trust
- West Midlands
- Below threshold - without competition
- 3 June 2026 to 2 June 2027
Birmingham Women's and Children's NHS Foundation Trust pays Biogene Ltd for annual licences to three genetic analysis programs: Mutation Surveyor, GeneMarker and ChimerMarker.
The trust uses the proprietary software in diagnostic work, to analyse genetic data and produce clinical reports.
The trust awarded the £69,628 contract directly, without competition. It runs from June 2026 to June 2027.
Contract ends June 2027
- What
- Genomic data platforms and bioinformatics
- Supplier
- Biogene Ltd
- Value
- £69,628
- How it was bought
- Below threshold - without competition
- Dates and next
- Jun 2026 to Jun 2027